All Stories

  1. Inhibition of parasite invasion by monoclonal antibody against epidermal growth factor-like domain of Plasmodium vivax merozoite surface protein 1 paralog
  2. Persistence of Long-lived Memory B Cells specific to Duffy Binding Protein in individuals exposed to Plasmodium vivax
  3. Cross-species analysis of apical asparagine-rich protein of Plasmodium vivax and Plasmodium knowlesi
  4. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar
  5. Correction for Wang et al., “Immunoprofiling of the Tryptophan-Rich Antigen Family in Plasmodium vivax ”
  6. Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009–2013)
  7. Genetic diversity of Plasmodium falciparum populations in southeast and western Myanmar
  8. Variable number of tandem repeats of 9 Plasmodium vivax genes among Southeast Asian isolates
  9. Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 8 in patients with P. vivax infection
  10. Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180
  11. Clinical and molecular surveillance of drug resistant vivax malaria in Myanmar (2009–2016)
  12. Molecular Evidence of Drug Resistance in Asymptomatic Malaria Infections, Myanmar, 2015
  13. Molecular surveillance of artemisinin resistance falciparum malaria among migrant goldmine workers in Myanmar
  14. Characterization of Caveola-Vesicle Complexes (CVCs) Protein, PHIST/CVC-8195 in Plasmodium vivax
  15. Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status
  16. Characterization of Pv92, a Novel Merozoite Surface Protein of Plasmodium vivax
  17. Effective High-Throughput Blood Pooling Strategy before DNA Extraction for Detection of Malaria in Low-Transmission Settings
  18. Challenges encountered by local health volunteers in early diagnosis and prompt treatment of malaria in Myanmar artemisinin resistance containment zones
  19. Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain
  20. Correction: Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen
  21. Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen
  22. Evaluation of the behaviour change communication and community mobilization activities in Myanmar artemisinin resistance containment zones
  23. Identification of Immunodominant B-cell Epitope Regions of Reticulocyte Binding Proteins in <i>Plasmodium vivax</i> by Protein Microarray Based Immunoscreening
  24. Immunoprofiling of the Tryptophan-Rich Antigen Family in Plasmodium vivax
  25. Molecular Assessment of Artemisinin Resistance Markers, Polymorphisms in the K13 Propeller, and a Multidrug-Resistance Gene in the Eastern and Western Border Areas of Myanmar
  26. Comparative study on Toxoplasma infection between Malaysian and Myanmar pregnant women
  27. Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia
  28. Spatial distribution, work patterns, and perception towards malaria interventions among temporary mobile/migrant workers in artemisinin resistance containment zone
  29. Challenges in universal coverage and utilization of insecticide-treated bed nets in migrant plantation workers in Myanmar
  30. Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar
  31. Field evaluation of HRP2 and pan pLDH-based immunochromatographic assay in therapeutic monitoring of uncomplicated falciparum malaria in Myanmar